Scientific title: TrialNet Transcriptomic Pipeline
Principle Investigator: Dr Eoin McKinney
Institution: University of Cambridge
Duration of award: November 2018 – October 2020
We know that there are earlier stages of type 1 diabetes, before symptoms develop. These earlier stages take place unnoticed, before the immune system extensively damages the pancreas. If we could get a better understanding of these early processes, it could help us spot who’s at risk of developing type 1 diabetes, and inform the development of treatments to slow or stop the immune system attack before the pancreas sustained further damage.
The aim of the project is to get a better understanding of the early stages of type 1 diabetes, before symptoms even become apparent. To do this, the project will analyse blood samples obtained as part of the TrialNet programme. Overall, this will help us to develop treatments to slow or stop the progression of type 1 diabetes.
Click on the image below to download a poster about Dr McKinney’s project.